Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE-Reference-Cited by-同舟云学术

Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

Published:2013-04 Issue:11 Volume:105 Page:812-822
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Mavaddat Nasim,Peock Susan,Frost Debra,Ellis Steve,Platte Radka,Fineberg Elena,Evans D. Gareth,Izatt Louise,Eeles Rosalind A.,Adlard Julian,Davidson Rosemarie,Eccles Diana,Cole Trevor,Cook Jackie,Brewer Carole,Tischkowitz Marc,Douglas Fiona,Hodgson Shirley,Walker Lisa,Porteous Mary E.,Morrison Patrick J.,Side Lucy E.,Kennedy M. John,Houghton Catherine,Donaldson Alan,Rogers Mark T.,Dorkins Huw,Miedzybrodzka Zosia,Gregory Helen,Eason Jacqueline,Barwell Julian,McCann Emma,Murray Alex,Antoniou Antonis C.,Easton Douglas F.,

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/105/11/812/18614656/djt095.pdf

Reference72 articles.

1. Anglian Breast Cancer Study Group. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group;Br J Cancer,2000

2. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies;Antoniou;Am J Hum Genet,2003

3. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions;Antoniou;Br J Cancer,2008

4. Variation of breast cancer risk among BRCA1/2 carriers;Begg;JAMA,2008

5. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program;Brose;J Natl Cancer Inst,2002

Cited by 750 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review;Cancer Treatment Reviews;2024-11

2. Advancing personalized medicine: Integrating statistical algorithms with omics and nano-omics for enhanced diagnostic accuracy and treatment efficacy;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

3. Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene;Genetics in Medicine;2024-10

4. Risk-reducing surgeries for breast cancer in Brazilian patients undergoing multigene germline panel: impact of results on decision making;Breast Cancer Research and Treatment;2024-09-10

5. Breast cancer after ovarian cancer in BRCA1 and BRCA2 pathogenic variant heterozygotes: Lower rates for 5 years post chemotherapy;Genetics in Medicine;2024-09